TrialDiabetes, obesity & metabolism2019

Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial.

Alberto J Lorenzatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.